280 related articles for article (PubMed ID: 22467424)
21. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
22. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
[TBL] [Abstract][Full Text] [Related]
23. Positive effect of alendronate on bone turnover in ovariectomised rats' osteoporosis: comparison of transdermal lipid-based delivery with conventional oral administration.
Boche M; Pokharkar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1078-1089. PubMed ID: 29987552
[TBL] [Abstract][Full Text] [Related]
24. Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
Guo L; Ma E; Zhao H; Long Y; Zheng C; Duan M
Int J Pharm; 2011 Nov; 420(1):172-9. PubMed ID: 21888960
[TBL] [Abstract][Full Text] [Related]
25. Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34).
Naito C; Katsumi H; Suzuki T; Quan YS; Kamiyama F; Sakane T; Yamamoto A
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30400376
[TBL] [Abstract][Full Text] [Related]
26. Effects of amines on percutaneous absorption of alendronate.
Whang J; Gwak H
Drug Dev Ind Pharm; 2011 May; 37(5):491-7. PubMed ID: 21126206
[TBL] [Abstract][Full Text] [Related]
27. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
28. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
29. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
30. Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
Ansari MD; Shafi S; Pandit J; Waheed A; Jahan RN; Khan I; Vohora D; Jain S; Aqil M; Sultana Y
Drug Deliv Transl Res; 2024 Jun; 14(6):1635-1647. PubMed ID: 37996726
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
[TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of insulin using microneedle rollers in vivo.
Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
[TBL] [Abstract][Full Text] [Related]
33. Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology.
Lin S; Cai B; Quan G; Peng T; Yao G; Zhu C; Wu Q; Ran H; Pan X; Wu C
Eur J Pharm Biopharm; 2018 Jan; 122():104-112. PubMed ID: 29042238
[TBL] [Abstract][Full Text] [Related]
34. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
35. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
[TBL] [Abstract][Full Text] [Related]
36. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
Zhao X; Li X; Zhang P; Du J; Wang Y
J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
[TBL] [Abstract][Full Text] [Related]
37. Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits.
Wu X; Chen Y; Gui S; Wu X; Chen L; Cao Y; Yin D; Ma P
Pharm Dev Technol; 2016 Nov; 21(7):787-793. PubMed ID: 26122959
[TBL] [Abstract][Full Text] [Related]
38. Rapidly Dissolving Microneedle Patches for Transdermal Iron Replenishment Therapy.
Maurya A; Nanjappa SH; Honnavar S; Salwa M; Murthy SN
J Pharm Sci; 2018 Jun; 107(6):1642-1647. PubMed ID: 29462631
[TBL] [Abstract][Full Text] [Related]
39. Transdermal insulin application system with dissolving microneedles.
Ito Y; Nakahigashi T; Yoshimoto N; Ueda Y; Hamasaki N; Takada K
Diabetes Technol Ther; 2012 Oct; 14(10):891-9. PubMed ID: 23013202
[TBL] [Abstract][Full Text] [Related]
40. The absorption of (99m)Tc-alendronate given by rectal route in rabbits.
Asikoğlu M; Ozguney I; Ozcan I; Orumlu O; Guneri T; Koseoğlu K; Ozkilic H
Pharm Dev Technol; 2008; 13(3):213-20. PubMed ID: 18484490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
